Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06478797

Early Resuscitation in Paediatric Sepsis Using Inotropes

Adrenaline in Early Sepsis Resuscitation in Children- A Randomised Controlled Pilot Study in the Emergency Department (ANDES CHILD)

Status
Not Yet Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
NATALIA LOPERA MUNERA · Academic / Other
Sex
All
Age
28 Days – 18 Years
Healthy volunteers
Not accepted

Summary

Septic shock in children still carries substantial mortality and morbidity. While resuscitation with 40-60 mL/kg intravenous fluid boluses remains a cornerstone of initial resuscitation, an increasing body of evidence indicates potential for harm related to high volume fluid administration. The investigators hypothesize that a protocol on early use of inotropes in children with septic shock is feasible and will lead to less fluid bolus use compared to standard fluid resuscitation. Here, the investigators describe the protocol of the Adrenaline in Early Sepsis Resuscitation in Children- A Randomised Controlled Pilot Study in the Emergency Department (ANDES CHILD)

Conditions

Interventions

TypeNameDescription
OTHERFluidSepsis will be treated with standardized therapy protocol, where participants receive fluids (balanced or non-balanced crystalloids, or colloids) to be resuscitated. Specifically, they will receive 40-60 ml/kg of fluids before the initiation of inotropes.
DRUGAdrenalinSepsis will be treated with early inotropes, where participants will receive adrenaline at a dose of 0.05 - 0.1 mcg/kg/min via peripheral intravenous, intraosseous, or central venous routes after the first fluid bolus of 20 ml/kg

Timeline

Start date
2024-07-01
Primary completion
2025-07-01
Completion
2025-12-01
First posted
2024-06-27
Last updated
2024-06-27

Locations

4 sites across 3 countries: Argentina, Bolivia, Paraguay

Source: ClinicalTrials.gov record NCT06478797. Inclusion in this directory is not an endorsement.